[Mianserin and imipramin in depressive conditions (author's transl)]. 1977

M Zapletálek, and H Hanus, and K Kudrnová

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008297 Male Males
D008803 Mianserin A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors. Lerivon,Mianserin Hydrochloride,Mianserin Monohydrochloride,Org GB 94,Tolvon,Hydrochloride, Mianserin,Monohydrochloride, Mianserin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Zapletálek, and H Hanus, and K Kudrnová
October 1979, Fortschritte der Neurologie, Psychiatrie, und ihrer Grenzgebiete,
M Zapletálek, and H Hanus, and K Kudrnová
September 1978, Deutsche medizinische Wochenschrift (1946),
M Zapletálek, and H Hanus, and K Kudrnová
January 1981, L'Encephale,
M Zapletálek, and H Hanus, and K Kudrnová
January 1979, Annales de biologie clinique,
M Zapletálek, and H Hanus, and K Kudrnová
January 1981, L'Encephale,
M Zapletálek, and H Hanus, and K Kudrnová
January 1978, Acta psychiatrica Belgica,
M Zapletálek, and H Hanus, and K Kudrnová
January 1978, Acta psychiatrica Belgica,
M Zapletálek, and H Hanus, and K Kudrnová
July 1979, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
M Zapletálek, and H Hanus, and K Kudrnová
January 1978, Acta psychiatrica Belgica,
M Zapletálek, and H Hanus, and K Kudrnová
August 1977, Ceskoslovenska psychiatrie,
Copied contents to your clipboard!